comprehensive -WSS

comprehensive

author：entertainment 2025-09-30 22:04:50 - browse：74

the U.S. Medicare Handbook is photographed in Washington. — Pablo Martinez Monsivais/AP

Roughly 33.4 million adults older than 65 and people with disabilities were enrolled in a Medicare Advantage plan as the calendar flipped to 2024 — another year of steady, albeit slower, growth for the taxpayer-funded program.

Enrollment increased 7.1% year over year, which would make this year’s annual growth rate identical to last year’s, according to new federal Medicare Advantage enrollment data analyzed by STAT.

The data reinforce how America’s Medicare program continues to shift toward a more privatized version that has not saved any money for taxpayers, has been linked to inappropriate coding practices, and has restricted care for older and vulnerable patients. And even though the federal government made several changes to Medicare Advantage for 2024 — changes that were vehemently opposed by the health insurance industry — the program’s growth has not been stunted, nor did insurers dramatically slash their offerings.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Apple Vision Pro: A first look at health apps on the new VR headset

knowledge

focus

WSS

Time to name cancers by genetics, not organ of origin, expert says

Do digital therapeutics have a future in medicine?

SAMSHA loosens regulations on methadone treatment centers

Novo Nordisk to expand supply of Wegovy for U.S. patients

Covid misinformation case heads to Supreme Court

Woodcock on FDA’s accelerated approval and her next chapter

hotspot

comprehensive

focus

Guidelines to prevent youth baseball injuries need more muscle

Senate panel puts off hardest PBM reforms for another day

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Congressmen charge Covid hearing ‘could have been an email’

Peter Hotez and the public health issue of online harassment

Some dementia cases could be undiagnosed liver disease

How one medical school became remarkably diverse

Novo Nordisk to expand supply of Wegovy for U.S. patients

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Vertex non

hotspot

Cognito secures funding to test medical device for Alzheimer's

The real point of Kenneth Smith’s execution by nitrogen gas

Juul spent big to court Black leaders to promote its e

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

What it's like to live with paralysis for one psychologist

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

focus

knowledge

focus

hotspot